drugset
drugset / Trial / NCT03766373

Evaluation of Safety and Reduction of Ear Pain in Adults With Acute Otitis Media and Reduction of Ear Pain in Adults With Acute Otitis Media

NCT03766373 ↗

Phase 1 Completed 24 enrolled Novus Therapeutics, Inc
RandomizedParallel-groupQuadruple-blindOther

Summary

The purpose of this study is to evaluate the Safety and Reduction of Ear Pain in Adults with Acute Otitis Media.

Timeline

Start
2019-01-07
Primary completion
2019-01-30
Completion
2019-01-30

Drugs

EvaluationDrugModalityDoseRoute
Subject OP0201 Unknown 20 mg —

Indications

otitis media